How to Administer Intranasal Lidocaine Step by Step

Intranasal lidocaine is delivered by one of two straightforward methods: soaking a long cotton-tipped applicator in lidocaine solution and threading it along the nasal passage, or using a spray device to atomize the solution directly into the nostril. Both approaches aim to bathe the mucous membranes in local anesthetic, and the choice between them depends on the clinical goal, available equipment, and how deep the lidocaine needs to reach. The technique is simple enough that some protocols allow self-administration at home, but a few details in positioning, timing, and dosing make the difference between a procedure that works and one that doesn’t.

Gather Your Supplies First

The two methods call for slightly different setups. For the cotton-tipped applicator technique, you need a 10-centimeter cotton-tipped applicator (longer than a standard Q-tip) and a topical anesthetic, typically 1 to 4 percent lidocaine solution. For the atomizer technique, you need a mucosal atomization device attached to a syringe, along with 2 percent lidocaine. In either case, many clinicians also have a nasal decongestant on hand, such as oxymetazoline spray, to shrink the nasal tissues before the lidocaine goes in.

Using a decongestant first isn’t just about comfort. A study comparing premedication methods for nasal procedures found that combining a decongestant with lidocaine reduced pain significantly compared to using a decongestant alone, and also improved the clinician’s view inside the nose by shrinking swollen turbinates.¹ In surgical settings, oxymetazoline paired with lidocaine has been used as an effective alternative to cocaine pledgets, providing both anesthesia and vasoconstriction without the regulatory and safety baggage of cocaine.²

Positioning the Patient

Head position matters more than people expect. For the cotton-tipped applicator method, the patient’s head should be placed in what clinicians call the “sniffing position”: the neck slightly flexed forward with the chin tilted up, as if you were leaning in to smell something. This alignment straightens out the path from the nostril to the back of the nasal cavity, making it easier to advance the applicator without resistance or discomfort.

For the spray or atomizer method, the patient can be lying down. One protocol for treating post-dural puncture headache had patients lie flat with the upper body slightly raised when tolerated.³ For self-administered nasal sprays targeting the sphenopalatine ganglion area, patients have been instructed to spray into one nostril, then lie on their back with the head tilted toward the same side for five minutes before repeating on the opposite side.⁴ Tilting the head helps gravity pull the solution toward the target structures at the back of the nasal cavity rather than letting it drain forward or down the throat.

The Cotton-Tipped Applicator Technique

This method is the more targeted of the two and is commonly used when the goal is to reach the sphenopalatine ganglion region, a cluster of nerve structures tucked behind the nasal cavity. The American College of Emergency Physicians describes the procedure in five steps:⁵

Soak the tip: Dip the cotton end of a 10-centimeter applicator in lidocaine solution (1 to 4 percent) until it is thoroughly saturated.
Insert gently: With the patient in the sniffing position, slide the soaked applicator into the nostril. Advance it slowly and steadily along the upper border of the middle turbinate, the bony shelf partway up the nasal cavity.
Advance to the back wall: Keep guiding the applicator until it reaches the posterior wall of the nasopharynx. You should feel a gentle stop when the tip contacts the back wall. Do not force it.
Leave it in place: Let the applicator sit for 10 to 20 minutes. The cotton wicks lidocaine onto the surrounding mucosa during this time.
Remove and reassess: After the dwell time, withdraw the applicator and check whether the patient’s symptoms have improved.

The procedure is typically done on both sides. It can feel odd, and patients sometimes report a pressure sensation as the applicator passes the turbinates, but the lidocaine itself begins numbing the tissue on contact. A word of caution: this technique is sometimes loosely called a “sphenopalatine ganglion block,” but researchers have pointed out that simply placing lidocaine on the nasal mucosa is not the same as a true nerve block of the sphenopalatine ganglion, which sits deeper within the bony pterygopalatine fossa and houses parasympathetic, sympathetic, and trigeminal sensory fibers.⁶ The mucosal application may still relieve headache through local anesthetic effects on trigeminal nerve endings in the area, but calling it a ganglion “block” overstates what the drug is physically reaching.

The Atomizer or Spray Technique

This method is faster and less invasive. Instead of threading anything deep into the nose, a mucosal atomization device converts the lidocaine into a fine mist that coats the nasal lining. The procedure, again per ACEP guidelines, goes like this:⁵

Load the device: Attach a mucosal atomization device to a 5-milliliter syringe and draw up 2 percent lidocaine.
Spray both sides: Deliver about 2 milliliters of lidocaine into each nostril.
Hold pressure: After spraying, press gently on the nostril for about 30 seconds to help the solution stay in contact with the mucosa rather than dripping out.
Wait and reassess: Check on the patient in 10 to 15 minutes.

The atomizer method distributes lidocaine more broadly across the nasal surfaces, which makes it a good fit for general nasal anesthesia before endoscopy or similar procedures. It doesn’t deliver the drug as deeply or precisely as the applicator technique, but for many uses that broad coverage is exactly what you want. Self-administered nasal spray protocols for migraine follow a similar logic: spray, tilt, wait, repeat on the other side.⁴

Timing and What to Expect

Lidocaine works quickly through nasal mucosa. A meta-analysis of randomized controlled trials found that patients who received intranasal lidocaine for acute migraine had lower pain intensity within five minutes compared to controls, and the benefit was even clearer at fifteen minutes.⁷ An emergency department study similarly found significantly lower pain scores in the lidocaine group at all measured time points after administration, with the effect holding for both primary and secondary headache types.⁸

Despite that fast onset, absorption through the nasal lining is incomplete. A pharmacokinetic study measuring blood levels after intranasal lidocaine found that bioavailability averaged only about 26 percent and varied widely between individuals, ranging from as low as 5 percent to as high as 48 percent.⁹ This high variability helps explain why some people get strong relief while others barely notice the effect. The drug reaches peak blood levels in under an hour, which is relevant for understanding both how long the benefit lasts and how much enters the systemic circulation.

Common Side Effects

The most frequently reported side effects are mild and local. A trial of intranasal lidocaine 8 percent spray for trigeminal neuralgia found that all fifteen patients who experienced side effects reported local irritation only: burning, stinging, or numbness in the nose and around the eye. One patient also noticed a bitter taste and numbness in the throat. No one had serious adverse events, and there were no problems with swallowing or speaking.¹⁰

The bitter taste is nearly universal. Lidocaine draining down the back of the throat produces a pronounced unpleasant flavor and a sensation of throat numbness that some patients find more bothersome than the nasal discomfort itself. This isn’t dangerous, but warning people about it beforehand helps manage expectations. The burning sensation tends to be brief, peaking in the first minute or two and fading as the numbing takes hold.

Research on reducing intranasal discomfort in general has shown that lidocaine can actually help buffer the sting of other nasally administered drugs. A study in a pediatric setting found that pretreating the nose with lidocaine significantly reduced the intranasal discomfort scores associated with a subsequent acidic drug solution.¹¹

Safety Considerations

Intranasal lidocaine at standard doses is generally safe, but a few situations call for extra caution. The nasal lining is highly vascular, and absorption increases substantially when the mucosa is damaged. A case report of fatal stroke following intranasal lidocaine underscored that topical lidocaine solutions should not be applied to open wounds or abraded skin, because vascularized nasal passages can absorb the drug rapidly enough to produce dangerous systemic levels.¹² If a patient has active nosebleeds, recent nasal surgery, or visible mucosal erosion, intranasal lidocaine should be avoided or used only with extreme caution and reduced dosing.

Systemic lidocaine toxicity, while rare from nasal application at standard concentrations, follows a recognizable progression: lightheadedness and tingling around the mouth come first, followed by tinnitus, visual disturbances, and in severe cases, seizures or cardiac arrhythmias. The variable bioavailability noted earlier means that some individuals absorb nearly half of the applied dose into the bloodstream, putting them closer to the toxic threshold than average. Staying within recommended concentrations (typically 2 to 4 percent) and volumes, and monitoring the patient for at least 15 minutes after application, substantially reduces this risk.

Patients with known lidocaine or amide-type local anesthetic allergies (which are rare but do exist) should not receive intranasal lidocaine. People with significant liver disease metabolize lidocaine more slowly, which can push blood levels higher than expected from a standard dose. And for headache treatment specifically, the meta-analysis on intranasal lidocaine for migraine found that its beneficial effects disappeared when an antiemetic was co-administered, suggesting a possible interaction that clinicians should keep in mind.⁷

Using Intranasal Lidocaine in Children

The nasal route is appealing in pediatric settings because it avoids needles. A study evaluating intranasal lidocaine as a premedicant before intranasal midazolam in children found that a single puff of lidocaine spray (10 milligrams per puff) prevented any nasal discomfort related to the subsequent medication, with no side effects recorded in the cohort.¹³ In that context, lidocaine served as a comfort measure rather than the primary treatment, numbing the nasal passages so the child wouldn’t flinch when the sedative was sprayed in.

Dosing in children needs to be weight-based, and the total milligram dose matters more than the concentration. Pediatric nasal passages are smaller and more vascular relative to body size, so the same volume that’s routine in an adult can produce higher blood levels in a child. In practice, many protocols use a single spray of a low concentration (2 percent or less) per nostril, keeping the total dose well within safe limits.

How Lidocaine Compares to Other Nasal Anesthetics

Lidocaine is the most commonly used nasal anesthetic, but it isn’t necessarily the strongest. A head-to-head comparison of cocaine, lidocaine, and tetracaine for topical nasal anesthesia found that tetracaine mixed with oxymetazoline produced greater increases in sensation threshold and greater decreases in pain perception than either lidocaine or cocaine at both 10 and 70 minutes after application.¹⁴ A separate trial comparing lidocaine spray to tetracaine solution before nasal surgery also found that the tetracaine group had lower mean pain scores.¹⁵

So why is lidocaine still the default? Availability, familiarity, and safety profile. Tetracaine is harder to find in many emergency departments and clinics, and cocaine, while effective, carries regulatory restrictions, abuse potential, and cardiovascular risks that make it impractical for routine use. Lidocaine sits in a sweet spot: widely stocked, well understood, effective enough for most purposes, and with a long track record of safety in nasal application. When clinicians compared lidocaine with levobupivacaine (a longer-acting local anesthetic) for transnasal fiberoptic laryngoscopy, there was no significant difference in pain or sedation scores between the two.¹⁶ For most nasal procedures, lidocaine works well enough that switching to a more exotic agent adds complexity without a meaningful improvement.

Buffered Versus Plain Lidocaine

Lidocaine solutions are acidic, which is part of why they sting going in. Adding sodium bicarbonate to raise the pH (buffering) is a well-known trick for injectable lidocaine, where it reliably reduces the pain of injection. Naturally, researchers have tested the same idea for nasal use. A randomized controlled trial comparing buffered and plain lidocaine for topical nasal anesthesia before flexible laryngoscopy found that the buffered group had a slightly lower average pain score, but the difference was not statistically significant.¹⁷

The surprising twist was that the plain lidocaine group actually reported less burning sensation, less throat discomfort, and fewer headaches than the buffered group, with those differences reaching statistical significance. The authors suggested that the buffering process may have altered the lidocaine’s stability or produced byproducts that irritated the mucosa in unexpected ways. For now, the evidence doesn’t support routinely buffering lidocaine for nasal use the way you would for a skin injection. Plain lidocaine stings briefly, but it appears to cause less overall discomfort in the nose than the buffered version.

From Cocaine to Lidocaine

The idea of numbing the nose with a topical solution is older than you might think. The first clinical use of local anesthesia was in 1884, when the Austrian physician Karl Koller applied cocaine to the eye for surgery, prompted by his friend Sigmund Freud’s interest in the coca plant’s properties.¹⁸ Cocaine quickly became the go-to topical anesthetic for nasal and throat procedures, but its toxic effects were identified almost as quickly, and deaths among both patients and medical staff who became addicted forced the field into what historians have described as a crisis. The search for safer alternatives drove decades of organic chemistry, producing a succession of synthetic local anesthetics. Lidocaine, synthesized in the 1940s, belonged to a newer chemical family (amino amides) that proved more stable and far less prone to allergic reactions than the older cocaine-derived agents. Its combination of safety, rapid onset, and predictable behavior made it the workhorse of local anesthesia across virtually every medical specialty, nasal application included.

1
Clinical and Experimental Otorhinolaryngology. Premedication Methods in Nasal Endoscopy: A Prospective, Randomized, Double-Blind Study
2
PubMed. Comparison of oxymetazoline and lidocaine versus cocaine for outpatient dacryocystorhinostomy
3
PubMed Central. Intranasal Lidocaine Administration via Mucosal Atomization Device: A Simple and Successful Treatment for Postdural Puncture Headache in Obstetric Patients
4
Journal of Anesthesia and Anesthetic Drugs. Retrospective Chart Review: The Feasibility of a Self-Administered Nasal Spray Targeting the Sphenopalatine Ganglion (SPG) in Treatment of Chronic Migraine
5
American College of Emergency Physicians. Minimally Invasive Procedures for Headaches
6
PubMed. Topical intranasal lidocaine is not a sphenopalatine ganglion block
7
PubMed Central. Intranasal lidocaine for acute migraine: A meta-analysis of randomized controlled trials
8
PubMed Central. Evaluation of efficacy of intra-nasal lidocaine for headache relief in patients refer to emergency department
9
PubMed Central. The bioavailability of intranasal lignocaine
10
British Journal of Anaesthesia. Intranasal lidocaine 8% spray for second-division trigeminal neuralgia
11
Pediatric Dentistry. Reducing the Pain of Intranasal Drug Administration
12
PubMed Central. Case Study of Fatal Stroke Following Intranasal Lidocaine
13
PubMed. Intranasal lidocaine and midazolam for procedural sedation in children
14
PubMed. Cocaine, lidocaine, tetracaine: which is best for topical nasal anesthesia?
15
B-ENT. Lidocaine spray versus tetracaine solution for monopolar submucosal diathermy for inferior turbinate hypertrophy
16
PubMed. Comparison of lidocaine and levobupivacaine in transnasal fiberoptic laryngoscopy
17
PubMed. Buffered Lidocaine for Topical Nasal Anesthesia: A Double-Blind Randomized Controlled Trial
18
PubMed. From cocaine to ropivacaine: the history of local anesthetic drugs